Zeke Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,456
| Closed | -$422K | – | 327 |
|
|
2021
Q1 | $422K | Sell |
1,456
-179
| -11% | -$51.9K | 0.03% | 150 |
|
|
2020
Q4 | $409K | Buy |
1,635
+324
| +25% | +$81.1K | 0.03% | 143 |
|
|
2020
Q3 | $297K | Sell |
1,311
-140
| -10% | -$31.7K | 0.03% | 161 |
|
|
2020
Q2 | $253K | Buy |
+1,451
| New | +$253K | 0.05% | 161 |
|
|
2020
Q1 | – | Sell |
-4,512
| Closed | -$689K | – | 299 |
|
|
2019
Q4 | $689K | Hold |
4,512
| – | – | 0.06% | 301 |
|
|
2019
Q3 | $597K | Hold |
4,512
| – | – | 0.05% | 326 |
|
|
2019
Q2 | $640K | Hold |
4,512
| – | – | 0.06% | 293 |
|
|
2019
Q1 | $655K | Sell |
4,512
-4,182
| -48% | -$607K | 0.06% | 299 |
|
|
2018
Q4 | $984K | Buy |
+8,694
| New | +$984K | 0.09% | 204 |
|